News Banner

tapros ophthalmic solution Complete specifications

Just fill in the form below, click submit, you will get the price list, and we will contact you within one working day. Please also feel free to contact us via email or phone. (* is required).

  • Santen Announces Approval of TAPROS

    2019-9-2 · TAPROS ophthalmic solution 0.0015%) タプロスミニ点眼液 0.0015% ( TAPROS Mini ophthalmic solution 0.0015%) 一般名 タフルプロスト( Tafluprost) 含有量( 1mL 中) 15 μg 患者向医薬品ガイドについて ...

    Get Price
  • News Release - Santen

    2015-8-25 · TAPROS, while Asahi Glass conducted the active pharmaceutical ingredient development. In Japan, TAPROS. has been sold since December 2008 as . TAPROS. Ophthalmic Solution 0.0015%, and is expanded over 60 countries at this time. Glaucoma is a disease characterized by optic nerve disorder and progressive visual field defects

    Get Price
  • Tafluprost - Santen Pharmaceutical - AdisInsight

    2013-9-20 · ingredient in TAPROS Ophthalmic Solution 0.0015%, an original glaucoma and ocular hypertension treatment co-developed by Santen and Asahi Glass Co., Ltd. (Tokyo) and launched in 2008. Glaucoma is a disorder characterized by optic nerve damage and progressive visual field loss resulting from abnormally elevated intraocular pressure (IOP).

    Get Price
  • Tafluprost Ophthalmic Solution 0.0015 %: A Review in ...

    Tafluprost - Santen Pharmaceutical Alternative Names: AFP 168; DE-085; DE-118; MK-2452; Saflutan; Taflotan; Tapros; Tapros mini ophthalmic solution 0.0015%; Tapros ophthalmic solution 0.0015%; Zioptan Latest Information Update: 14 Mar 2021

    Get Price
  • [Optimization of benzalkonium chloride concentration

    2016-5-25 · Tafluprost ophthalmic solution 0.0015 % preserved with benzalkonium chloride (BAK) 0.001 % is available in several Asian countries, including Japan. In pivotal trials, BAK-preserved tafluprost ophthalmic solution 0.0015 % lowered intraocular pressure (IOP) more effectively than placebo in Asian patients with normal-tension glaucoma and was at least as effective as latanoprost ophthalmic ...

    Get Price
  • 206289Orig1s000 - Food and Drug Administration

    Optimization of benzalkonium chloride (alkyl dimethylbenzylammonium chloride: BAK) concentration as preservative in 0.0015% tafluprost ophthalmic solution (Tapros 0.0015% ophthalmic solution), an anti-glaucoma medicine, was examined from the points of ocular surface safety and preservative efficacy. …

    Get Price
  • APPLICATION NUMBER: 203168Orig1s000

    2015-3-11 · This new drug application provides for the use of Atropine Sulfate Ophthalmic Solution, USP, 1% for cycloplegia, mydriasis, and penalization of the healthy eye in the treatment of amblyopia. We have completed our review of this application, as amended. It is approved, effective on the

    Get Price
  • |NIPH Clinical Trials Search

    Complete: follow-up continuing: Health condition(s) or Problem(s) studied: Glaucoma: Date of first enrollment: 2008/12/01: Target sample size: 10: Countries of recruitment: Japan: Study type: Interventional: Intervention(s) TAPROS ophthalmic solution 0.0015%

    Get Price
  • UMIN Clinical Trials Registry

    Investigation for the effect of Tapros ophthalmic solution monotherapy on the bacterial flora of conjunctival sacs: Date of disclosure of the study information: 2018/05/10: Last modified on: 2019/10/31

    Get Price
  • Cytotoxicity of prostaglandin analog eye drops

    2010-8-19 · The detailed drug comparison included the newly available preserved Tapros and the order of cell viability rate was determined accordingly. Optimal exposure times and dilutions for cytotoxicity testing of ophthalmic solutions were also discussed. CVS 50 was useful for comparison of cell viability in …

    Get Price
  • Changes in Ocular Surface Characteristics after

    2017-8-2 · It is well known that the BAK concentration of PG-related TAPROS ® ophthalmic solution 0.0015% (BAK-preserved Tafluprost) is low (0.001%) in comparison with that (0.02%) of the current PG-related drug Xalatan ® eye drop 0.005% (BAK-preserved Latanoprost). Furthermore, in Japan, not only BAK but also TAPROS Mini ophthalmic solution 0.0015% ...

    Get Price
  • 206289Orig1s000 - Food and Drug Administration

    2015-3-11 · Cosmetic Act(FDCA)for Atropine Sulfate Ophthalmic Solution, USP,1%.We also refer to our correspondence dated November 6, 2013, stating that as the User Fee for this application was received by the Office of Financial Management on October 30, 2013, we would consider this date as the receipt date for this application.

    Get Price
  • APPLICATION NUMBER: 203168Orig1s000

    2013-7-15 · ophthalmic solution 0.7% are consistent with the results of those earlier trials. The most commonly reported adverse reactions in seen clinical trials conducted with bromfenac ophthalmic solution, 0.7%, occurred in 3-8% of patients and included anterior chamber inflammation, eye pain, foreign body sensation, photophobia, and vision blurred. 7.

    Get Price
  • Ophthalmic Solutions - Carbachol Intraocular Solution ...

    2021-4-29 · The International Pharmacopoeia (Ph. Int.) constitutes a collection of recommended procedures for analysis and specifications for the determination of pharmaceutical substances and dosage forms that is intended to serve as source material for reference or adaptation by any WHO Member State wishing to establish pharmaceutical requirements. The pharmacopoeia, or any part of …

    Get Price
  • The International Pharmacopoeia - WHO

    2014-5-30 · AMO COMPLETE Multi-Purpose Solution zRECALLING FIRM/MANUFACTURER Recalling Firm: Abbott Medical Optics Inc (AMO), Santa Ana, CA, by letter on July 28, 2010 Manufacturer: Advanced Medical Optics Manufacturing Spain, S.L., Alcobendas (Madrid), Spain zREASON A limited number of the flip top caps used during production of these solutions

    Get Price
  • Sterile Product Package Integrity Testing

    2021-6-26 · Riboflavin 5’-Phosphate Ophthalmic Solution Photrexa 0.146% Glaukos Corporation 未进口原研药品 美国橙皮书 42-21 壬二酸凝胶 Azelaic Acid Gel Finacea 15% Leo Pharma AS ...

    Get Price
  • 202514Orig1s000 - Food and Drug Administration

    2012-3-13 · Zioptan (tafluprost ophthalmic solution) 0.0015% 5 Study 77553 ) Study 77553, the Phase 3 open label study with 185 patients, was completed and summarized in the original Safety Update (May 2011). The study was performed to assess changes in ocular symptoms and signs in patients with ocular hypertension or primary open-angle glaucoma who were

    Get Price
  • UMIN Clinical Trials Registry

    IOP-lowering effect lasting for 24 hours of Tapcom combination ophthalmic solution switched from Tapros ophthalmic solution 0.0015% and Timoptol XE Ophthalmic Solution 0.5%. Date of disclosure of the study information: 2015/08/29: Last modified on: 2017/02/16

    Get Price
  • Santen ”TAPROS” ophthalmic solution 0.0015% 2.5ml

    A prostaglandin analogue ester prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Chemically, tafluprost is a fluorinated analog of prostaglandin F2-alpha. Tafluprost was approved for use in the U.S. on February 10, 2012.

    Get Price
  • Tapros - Uses, DMF, Dossier, Manufacturer, Supplier ...

    2013-3-12 · Opthalmic solution Xalatan ® ophthalmic solution 0.005% Tapros ® ophthalmic solution 0.0015% Lumigan ® ophthalmic solution 0.03% Travatan ® ophthalmic solution 0.004% Travatan-Z ® ophthalmic solution 0.004%; Active ingredient: Latanoprost 50 ìg/mL: Tafluprost 15 ìg/mL: Bimatoprost 0.3 mg/mL: Travoprost 40 ìg/mL

    Get Price
  • Safety comparison of additives in antiglaucoma ...

    2018-10-8 · Technical Specifications Document . ... Table 17 Comparative Physiochemical Data of Ophthalmic Solution Drug Products. 16. ... Is the Product an Ophthalmic Yes No If Yes, then complete …

    Get Price
  • Model Bioequivalence Data Summary Tables

    Effects of Tapcom Combination Ophthalmic Solution Switched from Tapros 0.0015% and Timoptol XE 0.5% Solutions Date of disclosure of the study information 2015/03/23 Last modified on 2020/03/10 ...

    Get Price
  • UMIN Clinical Trials Registry

    2021-7-9 · A Breakthrough Innovation. Our most advanced TECNIS ® IOL yet, going beyond the limits of current trifocals. Widest* range of continuous vision** with best near *,1-5. Superior image contrast † day and night, delivering vision that patients can trust 3. Excellent patient outcomes so they can enjoy the moments that matter most *,†,‡,6.

    Get Price
  • Tafluprost | C25H34F2O5 - PubChem

    2021-6-25 · Riboflavin 5’-Phosphate Ophthalmic Solution Photrexa 0.146% Glaukos Corporation 未进口原研药品 美国橙皮书 壬二酸凝胶 Azelaic Acid Gel Finacea 15% Leo Pharma AS 未进口原研药品 美国橙皮书 盐酸吉西他滨注射液 Gemcitabine Hydrochloride Injection

    Get Price
  • solution), Merck’s Once-Daily, Preservative-Free FDA ...

    2020-4-13 · NEWS RELEASE FDA Approves ZIOPTAN™ (tauprost ophthalmic solution), Merck’s Once-Daily, Preservative-Free Ophthalmic Medication 2/13/2012 ZIOPTAN is a New and Eective Prostaglandin Analog Option for Lowering Elevated Intraocular Pressure in Patients

    Get Price
  • Combination glaucoma treatment approved in

    2013-9-23 · Tapcom contains both timolol maleate and tafluprost. Tafluprost is the active ingredient in Tapros ophthalmic solution 0.0015%, an original glaucoma and ocular hypertension treatment co-developed by Santen and Asahi Glass Co., Ltd. and launched in 2008.

    Get Price
  • Comparison of Corneal Safety and Intraocular

    2019-9-9 · Purpose: The benzalkonium chloride (BAK) content of tafluprost ophthalmic solution (Tapros ®: tafluprost) has been reduced to balance corneal safety and preservative effectiveness (old formulation: 0.01%; new formulation: 0.001%).However, no reports have been published on its clinical effect. Therefore, we conducted a clinical research study to compare the safety of BAK-reduced tafluprost on ...

    Get Price
  • Summary of Consolidated Financial Results for the Nine ...

    2021-2-4 · Hyalein ophthalmic solution ¥7.2 billion (YoY +5.5%) Bacterial conjunctivitis Cravit ophthalmic solution ¥6.6billion (YoY -21.3%) Asia (excluding China) On a JPY basis, revenue in the nine months ended December 31, 2020 increased by 5.1% year-on-year (+7.6% excluding FX impact), to ¥13.0 billion.

    Get Price
  • Ophthalmic Solutions - Trypen Blue Ophthalmic

    Exporter of Ophthalmic Solutions - Trypen Blue Ophthalmic Solution, Hydroxy Propyl Methyl, Hydroxypropyl Methylcellulose and Hydroxy Propyl Methyl Cellulose Ophthalmic Solution offered by Ganga Ophthocare, Kannur, Kerala.

    Get Price
  • Ophthalmic Instruments,Ophthalmic

    Sai Vision Care, is one of the most prestigious manufacturer, supplier and exporter of a comprehensive range of Intraocular Lenses, Ophthalmic Surgical Products, Ophthalmic Intraocular Solutions, Foldable Lenses and Contact Lenses.The demand of our offered lens and other ophthalmic products are high as these are safe to use, free from infection, non-toxic, hygienic and durable.

    Get Price
  • Santen’s preservative-free glaucoma drug approved

    2013-1-24 · Santen Pharmaceutical Co., Ltd. announced that Japan's Ministry of Health, Labour and Welfare has granted manufacturing and marketing clearance to Tapros Mini Ophthalmic Solution 0.0015%  (taflup

    Get Price
  • Changes in Ocular Surface Characteristics after

    Purpose . The aim of the present study was to examine the effects of switching from Latanoprost ophthalmic solution containing a preservative to preservative-free Tafluprost ophthalmic solution or Tafluprost containing a preservative on ocular surfaces. Materials and Methods . Forty patients (40 eyes) with glaucoma (mean age: 62.0 ± 10.9 years) using Latanoprost with ...

    Get Price
  • Summary of Consolidated Financial Results for the Six ...

    2020-11-6 · Tapros ophthalmic solution ¥4.6 billion (YoY -2.3%) Tapcom ophthalmic solution ¥1.3 billion (YoY +3.9%) Cosopt ophthalmic solution ¥3.8 billion (YoY +0.7%) Eybelis ophthalmic solution ¥1.2 billion (YoY +89.8%) Dry Eye Diquas ophthalmic solution ¥6.1 billion (YoY -21.8%) Allergy

    Get Price
  • Effects of pre-surgical administration of

    2017-7-20 · The PG analogs used immediately prior to trabeculectomy were bimatoprost 0.03% (Lumigan ® Ophthalmic Solution; Senju Pharmaceutical Co., Ltd., Osaka, Japan), latanoprost 0.005% (Xalatan ® Ophthalmic Solution; Pfizer Inc., Tokyo, Japan), tafluprost 0.0015% (Tapros ® Ophthalmic Solution; Santen Pharmaceutical Co. Ltd., Osaka, Japan), and ...

    Get Price
  • USP Compounding Standards and Beyond-Use Dates

    2019-9-23 · USP Compounding Standards and Beyond-Use Dates (BUDs) June 3, 2019 Comparing BUDs between the official <795> and the revised <795> The revised chapter addresses Compounded Nonsterile Preparations (CNSPs) requiring shorter BUDs and

    Get Price
  • Global Ophthalmic Drugs Market Forecast 2019-2029: Dry ...

    2019-6-17 · Product Code: PHA0439. The global ophthalmic drugs market is expected to grow at a CAGR of 4.8% in the first half of the forecast period. The market is estimated at 25bn in 2018, dominated by the retinal disorder drugs segment.

    Get Price
  • TECNIS ® CL IOL | Johnson & Johnson Vision

    2021-7-7 · Do not store the cartridges at temperatures under 41°F (5°C) or over 86°F (30°C). For optimal performance use the AMO HEALON ® Ophthalmic Viscoelastic Solution. ATTENTION. Reference the labeling for a complete listing of Indications and Important Safety Information. PP2021CT4024

    Get Price